Fraud propensity and firm’s performance in healthcare setting: the role of CEO characteristics
| dc.contributor.advisor | Monteiro, Januario | |
| dc.contributor.author | Aleied, Dareen | |
| dc.date.accessioned | 2024-11-26T16:28:47Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Top managers’ fraud stirred public opinion (Zahra et al., 2005), and attracted academics due its high negative impact for both the firm itself and the stakeholders (Schnatterly et al., 2018). WorldCom, Enron, and Tyco are examples of leader’s fraud cases committed by CEOs (Schnatterly et al., 2018). Therefore, this study aims to discover why CEO fraud still happens by answering the following question: How does CEOs characteristics influence on financial statement fraud propensity and performance of large listed companies? | |
| dc.format.extent | 27 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14154/73822 | |
| dc.language.iso | en | |
| dc.publisher | University of East Anglia | |
| dc.subject | financial statement fraud | |
| dc.subject | Top manager fraud | |
| dc.title | Fraud propensity and firm’s performance in healthcare setting: the role of CEO characteristics | |
| dc.type | Thesis | |
| sdl.degree.department | Accounting | |
| sdl.degree.discipline | Accountitng and Finance | |
| sdl.degree.grantor | University of East Anglia | |
| sdl.degree.name | Master |